SCHEMBL19475333

SCHEMBL19475333

Nc1ccc(-c2cc(C(=O)O)c3cccc(Cl)c3n2)cn1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 1/20 0.55
PPARA Q07869 1/20 0.50
EIF4A1 P60842 1/20 0.50
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
DHODH Q02127 3/20 0.48
PDE10A Q9Y233 1/20 0.47
MOK Q9UQ07 1/20 0.47
MAPT P10636 4/20 0.47
PTGES O14684 1/20 0.46
ALDH1A1 P00352 1/20 0.46
ALOX5 P09917 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CASP7 P55210 1/20 0.46
HIF1A Q16665 1/20 0.46
HSD17B10 Q99714 1/20 0.46
AURKA O14965 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475456 0.86 PPARA (0.56) HAVCR2PPARAEIF4A1KDM4ELMNA
SCHEMBL8619739 0.83 PPARA (0.69) PPARAEIF4A1KDM4ELMNAHTT
SCHEMBL19475307 0.81 MOK (0.73) KDM4ELMNAMOKALDH1A1HPGD
SCHEMBL19475402 0.81 HAVCR2 (0.55) HAVCR2PPARAEIF4A1KDM4ELMNA
SCHEMBL19475455 0.78 ALDH1A1 (0.73) EIF4A1KDM4EDHODHMAPTPTGES
SCHEMBL19475364 0.76 KMT2A (0.69) PPARAEIF4A1KDM4EPDE10AMOK
SCHEMBL19475407 0.76 RXFP1 (0.65) HAVCR2PPARAEIF4A1LMNADHODH
Benzaldehyde SCHEMBL22471912 0.76 PPARA (0.59) PPARAEIF4A1KDM4ELMNAHTT
SCHEMBL15129827 0.73 HAVCR2 (0.50) HAVCR2PPARAEIF4A1KDM4EHTT
SCHEMBL16833684 0.72 HAVCR2 (0.50) HAVCR2PPARAEIF4A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 HAVCR2 2115/4885PPARA 799/4885EIF4A1 1966/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 HAVCR2 2115/4885PPARA 799/4885EIF4A1 1966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.